Onconetix Inc (ONCO : NASDAQ)
Common Stock
$0.91
USD
+0.26 (38.93%)
Last updated: 2026-09-23
Follow ONCO
ONCO
Onconetix Inc
WealthAwesomePerformance
1 Day
+38.93%
1 Week
+37.25%
1 Month
+38.72%
YTD
-8.54%
Key Statistics
Market Cap
$2.99M
52W High
$209.50
52W Low
$0.59
P/E Ratio
0.00
50 Day MA
$0.77
200 Day MA
$27.16
Beta
2.67
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/23/2026 | $0.66 | $1.15 | $0.66 | $0.91 | $0.91 | 31,435,100 |
| 9/21/2026 | $0.64 | $0.67 | $0.63 | $0.66 | $0.66 | 133,900 |
| 9/18/2026 | $0.67 | $0.68 | $0.64 | $0.64 | $0.64 | 171,300 |
| 9/17/2026 | $0.66 | $0.67 | $0.65 | $0.66 | $0.66 | 102,500 |
| 9/16/2026 | $0.64 | $0.69 | $0.64 | $0.66 | $0.66 | 122,800 |
| 9/15/2026 | $0.65 | $0.68 | $0.59 | $0.65 | $0.65 | 612,400 |
| 9/14/2026 | $0.76 | $0.78 | $0.64 | $0.64 | $0.64 | 553,600 |
| 9/11/2026 | $0.79 | $0.79 | $0.74 | $0.76 | $0.76 | 165,500 |
| 9/10/2026 | $0.82 | $0.84 | $0.77 | $0.78 | $0.78 | 172,900 |
| 9/9/2026 | $0.83 | $0.83 | $0.80 | $0.81 | $0.81 | 262,900 |
Analyst Price Targets
Based on 1 analyst covering ONCO · as of Sep 17, 2026
Wall Street analysts forecast ONCO stock price to rise 889.0% over the next 12 months.
Consensus
Hold3.00 / 5.00
Avg. Target
US$9.00
+889.0% Upside
Current Price
US$0.91
Last close
Analyst Breakdown (1 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ONCO's historical volatility
30-Day Vol
169.6%
Annualized
90-Day Vol
154.8%
Annualized
Trend (90d)
-29.8%
Annualized drift
90d Mean
US$0.82
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$0.88 | US$0.49 – US$1.58 |
| 60 trading days | US$0.85 | US$0.37 – US$1.94 |
| 90 trading days | US$0.82 | US$0.30 – US$2.25 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Onconetix Inc
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.
Financials
- Revenue (TTM)
- $645,824
- EBITDA
- $-7.67M
- Profit Margin
- 0.00%
- ROE (TTM)
- -105.23%
- EPS (Diluted)
- 790.92
- Book Value
- 3.55
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About ONCO.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| BENF | Beneficient Class A Common Stock | $2.90 | +438.73% |
| JAGX | Jaguar Animal Health Inc | $8.91 | +233.71% |
| WHLR | Wheeler Real Estate Investment Trust, Inc. | $5.44 | +190.91% |
| VSA | TCTM Kids IT Education Inc. | $3.64 | +83.84% |
| ARTL | Artelo Biosciences Inc | $7.31 | +76.14% |
| BFRG | Bullfrog AI Holdings, Inc. Common Stock | $0.95 | +58.33% |
| VTGN | VistaGen Therapeutics Inc | $0.37 | +46.54% |
| IPDN | Professional Diversity Network Inc | $5.42 | +38.97% |